Select Medical (NYSE:SEM) Price Target Raised to $40.00

Select Medical (NYSE:SEM - Get Free Report) had its target price increased by equities researchers at Royal Bank of Canada from $36.00 to $40.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an "outperform" rating on the health services provider's stock. Royal Bank of Canada's target price would suggest a potential upside of 24.57% from the stock's current price.

Several other research analysts have also commented on SEM. Benchmark reaffirmed a "buy" rating and issued a $39.00 price target on shares of Select Medical in a report on Friday. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, March 22nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $34.80.

Select Medical Stock Up 2.2 %

Shares of Select Medical stock traded up $0.68 during trading hours on Monday, hitting $32.11. 988,987 shares of the company's stock traded hands, compared to its average volume of 583,021. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30. The stock has a 50 day simple moving average of $28.42 and a 200-day simple moving average of $25.95. The company has a market cap of $4.18 billion, a PE ratio of 15.27, a PEG ratio of 1.24 and a beta of 1.38. Select Medical has a twelve month low of $21.28 and a twelve month high of $33.51.

Select Medical (NYSE:SEM - Get Free Report) last released its earnings results on Friday, February 23rd. The health services provider reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. The company had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. The company's revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.22 EPS. Equities research analysts anticipate that Select Medical will post 2.03 earnings per share for the current fiscal year.

Insider Buying and Selling at Select Medical

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the firm's stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $26.00, for a total transaction of $1,300,000.00. Following the completion of the transaction, the chairman now owns 6,789,668 shares of the company's stock, valued at $176,531,368. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 17.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Select Medical

Hedge funds have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC boosted its position in Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider's stock worth $198,000 after purchasing an additional 405 shares during the period. Watershed Asset Management L.L.C. boosted its holdings in Select Medical by 8.2% during the fourth quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider's stock valued at $253,000 after acquiring an additional 814 shares during the period. Paralel Advisors LLC grew its position in shares of Select Medical by 1.1% in the third quarter. Paralel Advisors LLC now owns 73,981 shares of the health services provider's stock valued at $1,870,000 after purchasing an additional 836 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Select Medical by 1.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,310 shares of the health services provider's stock worth $1,112,000 after purchasing an additional 858 shares during the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp acquired a new stake in Select Medical in the 3rd quarter valued at approximately $29,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.